Itolizumab [1116433-11-4]

MedChem Express

Itolizumab [1116433-11-4]

10

1116433-11-4

Research Use Only

Monoclonal

99.0

Itolizumab (Anti-Human CD6 Recombinant Antibody) is a humanized recombinant anti-CD6 monoclonal antibody (MAb) targeting the extracellular SRCR distal domain 1 of CD6. Itolizumab reduces T-cell proliferation and inhibits the production of pro-inflammatory cytokines, such as INF-gamma, TNFalpha and IL-6. Itolizumab can be used in the research of psoriasis, rheumatoid arthritis (RA), COVID-19[1][2][3].

-80°C

41116161